Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
Park HR, Kim J, Kim T, Jo S, Yeom M, Moon B, Choo IH, Lee J, Lim EJ, Park KD, Min SJ, Nam G, Keum G, Lee CJ, Choo H.
Park HR, et al. Among authors: park kd.
Bioorg Med Chem. 2013 Sep 1;21(17):5480-7. doi: 10.1016/j.bmc.2013.05.066. Epub 2013 Jun 11.
Bioorg Med Chem. 2013.
PMID: 23810676